Diagnostic Utility of T1201 Imaging

  • R. Schmoliner
  • R. Dudczak
Chapter
Part of the Developments in Nuclear Medicine book series (DNUM, volume 8)

Abstract

Since its introduction into medical diagnosis, Tl201 scintigraphy has provided important information concerning the non-invasive assessment of myocardial perfusion. The technique has been demonstrated to be of major importance in patients with suspected and documented coronary artery disease and provided also useful information in a variety of other cardiac disorders like cardiomyopathy, valve disease, right ventricular hypertrophy, and cardiac involvement in systemic diseases like sarcoidosis (1–19). The major clinical application of Tl201 imaging was reported in the field of coronary artery disease. In comparison to older noninvasive diagnostic tests considering ECG changes during exercise, Tl201 scintigraphy in combination with stress procedures has yielded high values of sensitivity and specificity in the detection of patients with coronary artery disease. Apart from the usual form of physical stress applying bicycle or treadmill exercise, the potential value of TI201 imaging has been considerably increased by the possibility to provoke stress conditions using high doses of intravenously given dipyridamole. This special type of stress is regarded as an important alternative in many patients unable to exercise adequately (20–28).

Keywords

Single Photon Emission Compute Tomography Left Anterior Descend Pretest Probability Multivessel Disease Coronary Stenos 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
This is a preview of subscription content, log in to check access.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Bailey IK, Griffith LSC, Rouleau J, Strauss HW, Pitt B, Thallium-201 myocardial perfusion imaging at rest and during exercise. Comparative sensitivity to electrocardiography in coronary artery disease. Circulation 55: 79, 1977PubMedGoogle Scholar
  2. 2.
    Beller GA, Quantitative Thallium-201 scintigraphy. Int. J. Cardiol. 5:234, 1984PubMedCrossRefGoogle Scholar
  3. 3.
    Berger BB, Watson DD, Taylor GJ, Craddock GB, Martin RP, Teates CD, Beller GA, Quantitative Thallium-201 exercise scintigraphy for detection of coronary artery disease. J. nucl. Med. 22: 585, 1981PubMedGoogle Scholar
  4. 4.
    Berman DS, Mason DT, Clinical nuclear cardiology. Grune and Stratton, New York, 1981Google Scholar
  5. 5.
    Bulkley BH, Rouleau JR, Whitaker JQ, Strauss HW, Pitt B, The use of 201-Thallium for myocardial perfusion imaging in sarcoid heart disease. Chest 72: 27, 1977PubMedCrossRefGoogle Scholar
  6. 6.
    Burow RD, Pond M, Schafer AW, Becker L. Circumferential profiles: A new method for computer analysis of Thallium-201 myocardial perfusion images. J. nucl. Med. 20: 771, 1979PubMedGoogle Scholar
  7. 7.
    Dunn RF, Freedman B, Bailey IK, Uren RF, Kelly DT, Exercise Thallium imaging: Location of perfusion abnormalities in single-vessel coronary disease. J. nucl. Med. 21: 717, 1980PubMedGoogle Scholar
  8. 8.
    Gutman J, Berman DS, Freeman M, Rozanski A, Maddahi J, Waxman A, Swan HJC, Time to completed redistribution of Thallium-201 in exercise nyocardial scintigraphy: Relationship to the degree of coronary artery stenosis. Amer. Heart J. 106: 989, 1983PubMedCrossRefGoogle Scholar
  9. 9.
    Hakki AH, Iskandrian AS, Segal EL, Kane SA, Use of exercise Thallium scintigraphy to assess extent of ischaemic myocardium in patients with left anterior descending artery disease. Brit. Heart J. 45: 703, 1981PubMedCrossRefGoogle Scholar
  10. 10.
    Hör G, Kanemoto N, 201-T1-myocardial scintigraphy: Current status in coronary artery disease, results of sensitivity/specificity in 3092 patients and clinical recommendations. Nucl. Med. 20: 136, 1981Google Scholar
  11. 11.
    Jengo JA, Freeman R, Brizendine M, Mena I, Detection of coronary artery disease: Comparison of exercise stress radionuclide angiocardiography and Thallium stress perfusion scanning. Amer. J. Cardiol. 45: 535, 1980PubMedCrossRefGoogle Scholar
  12. 12.
    Lenaers A, Block P, Van Thiel E, Lebedelle M, Becquevort P, Erbsmann F, Ermans AM, Segmental analysis of Thallium-201 stress myocardial scintigraphy. J. nucl. Med. 18: 509, 1977PubMedGoogle Scholar
  13. 13.
    Massie BM, Botvinick EH, Brundage BH, Correlation of Thallium-201 scintigrams with coronary anatomy: Factors affecting region by region sensitivity. Amer. J. Cardiol. 44: 616, 1979PubMedCrossRefGoogle Scholar
  14. 14.
    Melin JA, Piret LJ, Vanbutsele RJM, Rousseau MF, Cosyns J, Brasseur LA, Becker C, Detry JMR, Diagnostic value of exercise electrocardiography and Thallium myocardial scintigraphy in patients without previous myocardial infarction: A Bayesian approach. Circulation 63: 1019, 1981PubMedCrossRefGoogle Scholar
  15. 15.
    Patterson HE, Horowitz SF, Eng C, Rudin A, Meiler J, Halgash DA, Pichard AD, Goldsmith SJ, Herman MV, Gorlin R, Can exercise electrocardiography and Thallium-201 myocardial imaging exclude the diagnosis of coronary artery disease? Amer. J. Cardiol. 49: 1127, 1982CrossRefGoogle Scholar
  16. 16.
    Rigo P, Bailey IK, Griffith LSC, Pitt B, Burow RD, Wagner HN, Becker LC, Value and limitations of segmental analysis of stress Thallium myocardial imaging for localization of coronary artery disease. Circulation 61: 973, 1980PubMedGoogle Scholar
  17. 17.
    Ritchie JL, Myocardial perfusion Imaging. Amer. J. Cardiol. 49:1341, 1982PubMedCrossRefGoogle Scholar
  18. 18.
    Silber S, Fleck E, Klein U, Rudolph W, Wertigkeit der Thallium-201 Belastungsszintigraphie im Vergleich zur Belastungelektrokardiographie bei Patienten mit koronarer Herzerkrankung ohne Myokardinfarkt. Herz 4: 359, 1979PubMedGoogle Scholar
  19. 19.
    Smalling RW, The spectrum of Thallium-201 imaging in coronary artery disease (teaching-editorial). J. nucl. Med. 24: 854, 1983PubMedGoogle Scholar
  20. 20.
    Albro PC, Gould LK, Westcott RJ, Hamilton GW, Ritchie JL, Williams DL, Noninvasive assessment of coronary stenoses by myocardial imaging during pharmacologic coronary vasodilatation. III. Clinical trial. Amer. J. Cardiol. 42: 751, 1978PubMedCrossRefGoogle Scholar
  21. 21.
    Demangeat JL, Constantinesco A, Mossard JM, Chambron J, Voegtlin R, Evaluation of myocardial perfusion and left ventricular function by 201-Thallium scintigraphy after dipyridamole. Eur. J. Nucl. Med. 6: 491, 1981PubMedCrossRefGoogle Scholar
  22. 22.
    Francisco DA, Collins SM, Go RT, Ehrhardt TC, Van Kirk OC, Marcus ML, Tomographic Thallium-201 myocardial perfusion scintigrams after maximal coronary artery vasodilatation with intravenous dipyridamole. Coirparison of qualitative and quantitative approaches. Circulation 66:370, 1982PubMedCrossRefGoogle Scholar
  23. 23.
    Gould LK, Noninvasive assessment of coronary stenoses by myocardial perfusion imaging during pharmacologic coronary vasodilatation. I. Physiologic basis and experimental validation. Amer. J. Cardiol. 41: 267, 1978Google Scholar
  24. 24.
    Gould KL, Westcott RJ, Albro PC, Hamilton GW, Noninvasive assessment of coronary stenoses by myocardial imaging during pharmacologic coronary vasodilatation. II. Clinical methodology and feasibility. Amer. J. Cardiol. 41: 279, 1978PubMedCrossRefGoogle Scholar
  25. 25.
    Josephson MA, Brown G, Hecht HS, Hopkins J, Pierce CD, Peterson RB, Noninvasive detection and localization of coronary stenoses in patients: Comparison of resting dipyridamole and exercise Thallium-201 myocardial perfusion imaging. Amer. Heart J. 103:1008, 1982PubMedCrossRefGoogle Scholar
  26. 26.
    Leppo J, Boucher CA, Okada RD, Newell RD, Strauss HW, Pohost G, Serial Thallium-201 myocardial imaging after dipyridamole infusion: Diagnostic utility in detecting coronary stenoses and relationship to regional wall motion. Circulation 66: 649, 1982PubMedCrossRefGoogle Scholar
  27. 27.
    Schmoliner R, Dudczak R, Kronik G, Kletter K, Hutterer B, Mösslacher H, Frischauf H, Die Aussagekraft der Thallium-Szintigraphie nach Dipyridamol in der Diagnostik der koronaren Herzkrankheit. Z. Kardiol. 69: 179, 1980Google Scholar
  28. 28.
    Schmoliner R, Dudczak R, Kronik G, Homan R, Mösslacher H, Änderungen der 1 inksventrikulären Auswurffraktion unter Belastung und der Thallium-201 -Szintigraphie nach Dipyridamol bei Xoronarpatienten. Wien. Klin. Wschr. 96, 243, 1984Google Scholar
  29. 29.
    Lebowitz E. Greene MW, Bradley-Moore P, Atkins H, Ansari A, Richard P, Belgrave E, Tl–201 for rredical use. J. nucl. Med. 14: 421, 1973Google Scholar
  30. 30.
    Grosze-Heitmeyer W, Görtz P, Drüke P, Mönninghoff W, Most E, Müller U, Bender F, Dipyridamol-Test und koronare Herzkrankheit. Med. Welt 33:960, 1982.Google Scholar
  31. 31.
    Osterspey A, Jansen W, Tauchert M, Eigl J, Höpp H, Behrenbeck DW, Hilger HH, Stellenwert des Dipyridamol-Tests in der Diagnostik der koronaren Herzkrankheit. Dtsch. med. Wschr. 108: 1469, 1983Google Scholar
  32. 32.
    Schmoliner R, Slany J, Kronik G, Mösslacher H, Die Aussagekraft der Dipyridamoltests für die Diagnostik der koronaren Herzkrankheit. Wien. Klin. Wschr. 91: 460, 1979PubMedGoogle Scholar
  33. 33.
    Slany J. Mösslacher H, Imhof H, Bodner P, Untersuchungen zum coronary steal Phänomen bei koronarer Herzkrankheit. Verh. Dtsch. Ges. Kreislauf forschg. 40: 435, 1974Google Scholar
  34. 34.
    Slany J, Mösslacher H, Kronik G, Schmoliner R, Einflusz von Dipyridamol auf das Ventrikulogram bei koronarer Herzkrankheit. Z. Kardiol. 66: 389, 1977Google Scholar
  35. 35.
    Tauchert M, Behrenbeck DW, Hötzel J, Hilger HH, Ein neuer pharmakologischer Test zur Diagnose der Koronarinsuffizienz. Dtsch. Med. Wschr. 101: 35, 1976PubMedCrossRefGoogle Scholar
  36. 36.
    Tavazzi L, Previtali M, Salerno JA, Chimienti M, Ray M, Medici A, Specchia G, Bobba P, Dipyridamole-test in angina pectoris: Diagnostic value and pathophysiological implications. Cardiology 69: 34, 1982PubMedCrossRefGoogle Scholar
  37. 37.
    Afonso S, O’Brien GS, Enhancement of coronary vasodilator action of adenosine triphosphate by dipyridamole. Circulat. Res. 20: 403, 1967PubMedGoogle Scholar
  38. 38.
    Afonso S, Inhibition of coronary vasodilating action of dipyridamole and adenosine by aminophylline in the dog. Circulat. Res. 26: 743, 1970PubMedGoogle Scholar
  39. 39.
    Klabunde RE, Effects of dipyridamole on postischemic vasodilatation and extracellular adenosine. Amer. J. Physiol. 244: 273, 1983Google Scholar
  40. 40.
    Massie BM, Wisneski J, Kramer B, Hollenberg M, Gertz E, Stern D, Comparison of myocardial Thallium-201 clearance after maximal and submaximal exercise: Implications for diagnosis of coronary heart disease: Concise communication. J. nucl. Med. 23 (N): 381, 1982PubMedGoogle Scholar
  41. 41.
    Schmoliner R, Dudczak R, Kronik G, Hutterer B, Kletter K, Mösslacher H, Frischauf H, Thallium-201 -Myokardszintigraphie nach hochdosierter Dipyridamolgabe. Z. Kardiol. 70: 111, 1981PubMedGoogle Scholar
  42. 42.
    Gould KL, Quantitative imaging in nuclear cardiology. Circulation 66: 1141, 1982PubMedCrossRefGoogle Scholar
  43. 43.
    Goris ML, Daspit SG, McLaughlin P, Kriss JP, Interpolative background subtraction. J. nucl. Med. 17: 744, 1976PubMedGoogle Scholar
  44. 44.
    Maddahi J, Garcia EV, Berman DS, Waxman A, Swan BJC, Forrester J, Improved noninvasive assessment of coronary artery disease by quantitative analysis of regional stress myocardial distribution and washout of Thallium-201. Circulation 64: 924, 1981PubMedCrossRefGoogle Scholar
  45. 45.
    Dudczak R, Schitoliner R, Homan R, Kletter K, Frischauf H, Serial TI-201 images after hiqh dose dipyridamole: Diagnostic utility of Tl-201 washout analysis. Eur. J. Nucl. Med. 9: 147, 1984CrossRefGoogle Scholar
  46. 46.
    Wilson RA, Okada RD, Boucher CA, Guiney TE, Mc Kusick K, Pohost GM, Strauss HW, Influence of eating on serial exercise Thallium myocardial and lung clearance rates. Circulation 64: 242, 1981CrossRefGoogle Scholar
  47. 47.
    Wilson RA, Okada RA, Strauss HW, Pohost GM, Effect of glucose-insulin- potassium-infusion on Thallium myocardial clearance. Circulation 68: 203, 1983PubMedCrossRefGoogle Scholar
  48. 48.
    Diamond GA, Forrester JS, Analysis of probability as an aid in the clinical diagnosis of coronary artery disease. New Engl. J. Med. 300: 1350, 1979Google Scholar
  49. 49.
    Epstein SE, Implications of probability analysis on the strategy used for noninvasive detection of coronary artery disease. Amer. J. Cardiol. 46: 491, 1980PubMedCrossRefGoogle Scholar
  50. 50.
    Schmoliner R, Dudczak R, Kronik G, Kletter K, Mösslacher H, Frischauf H, Diagnostische Wertigkeit der Thallium-201-Szintigraphie nach Dipyridamol bei Patienten mit normokinetischem Ventrikel. Z. Kardiol. 72: 394, 1983PubMedGoogle Scholar
  51. 51.
    Wagner HN, Bayes’ Theorem: An idea whose time has come? Amer. J. Cardiol. 49:875, 1982Google Scholar
  52. 52.
    Hlatky M, Botvinick E, Brundage B, The independent value of exercise Thallium scintigraphy to physicians. Circulation 66: 953, 1982PubMedCrossRefGoogle Scholar
  53. 53.
    Schmoliner R, Dudczak R, Kronik C, Mösslacher H, Zangeneh M, Pollak Ch, Schurz B, Schoberwalter A, Homan R, Einflusz der Thallium-201 - Szintigraphie auf die klinische Einschätzung von Brustschmerzen. In: Radioaktive Isotope in Klinik und Forschung. Gasteiner Int. Symp. 1984, 16. Band, 1. Teil, p 415Google Scholar
  54. 54.
    Wilcken DEL, Paoloni RJ, Eikens E, Evidence for intravenous dipyridamole (Persantin) producing a “coronary steal” effect in the ischemic myocardium. Aust. N.Z.J. Med. 1: 8, 1971PubMedCrossRefGoogle Scholar
  55. 55.
    Hintze TH, Vatner SF, Dipyridamole dilates large coronary arteries in conscious dogs. Circulation 68: 1321, 1983PubMedCrossRefGoogle Scholar
  56. 56.
    Nott MW. The possible role of adenosine in the coronary dilator action of some pyrimldopyrimidines and pteridines. Brit. J. Pharmac. 39: 287, 1970Google Scholar
  57. 57.
    Schmoliner R, Kronik G, Dudczak R, Hutterer B, Mösslacher H, Frischauf H, Die Zuverlässigkeit der Thallium-201-Szintigraphie und der zweidimensionalen Echokardiographie in der Diagnostik von Infarktnarben. Med. Welt 32: 264, 1981PubMedGoogle Scholar
  58. 58.
    Schmoliner R, Dudczak R, Kronik G, Hutterer B, Kletter K, Mösslacher H, Frischauf H, Thallium-201 imaging after dipyridamole in patients with coronary multivessel disease. Cardiology 70: 145, 1983PubMedCrossRefGoogle Scholar
  59. 59.
    Pichard AD, Wiener I, Martinez E, Horowitz S, Patterson R, Meller J, Goldsmith S, Gor 1 in R, Herman MV, Septal myocardial perfusion imaging with Thallium-201 in the diagnosis of proximal left anterior descending coronary artery disease. Amer. Heart J. 102: 30, 1981PubMedCrossRefGoogle Scholar
  60. 60.
    Platia EV, Grunwald L, Mellits ED, Humphries JO, Griffith LSC, Clinical and arteriographic variables predictive of survival in coronary artery disease. Amer. J. Cardiol. 46: 543, 1980PubMedCrossRefGoogle Scholar
  61. 61.
    Schmoliner R, Dudczak R, Kronik G, Kletter K, Mösslacher H, Frischauf H, Erfassung von Stenosen des Ramus interventricularis anterior mittels Thallium-201 -Szintigraphie nach Dipyridamol. Herz/Kreislauf 15: 3, 1983Google Scholar

Copyright information

© Martinus Nijhoff Publishers, Dordrecht 1985

Authors and Affiliations

  • R. Schmoliner
  • R. Dudczak

There are no affiliations available

Personalised recommendations